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Introduction Objective
EFFECTIVENESS OF INTRAVENOUS LIDOCAIN IN PAIN 
CONTROL AND POSTOPERATIVE RECOVERY FROM 
ABDOMINAL SURGERY
Results of effectiveness
Conclusion
Today, abdominal surgeries are very common in most 
species. Concern for the well-being of patients leads to 
increasingly seeking more effective analgesic protocols, 
especially in those major surgeries that tend to be more 
painful.
• Lidocaine in humans is well studied but the mechanism by which it is useful in abdominal surgeries is not well known.
• It is widely used in veterinary medicine but the unknowns are even greater as there are few well-thought-out studies.
o Many inconsistencies in the results.
o Few samples.
• It is necessary to continue researching with this line and to give a justified use in these situations to lidocaine.
• Review the mechanism of action by which lidocaine may be 
effective in pain control and recovery from abdominal surgery.
• To evaluate bibliographically the effectiveness of lidocaine in 
postoperative abdominal surgery in humans.
• To evaluate bibliographically the effectiveness of lidocaine in 
postoperative abdominal surgery in veterinary medicine.
• Determine the protocols in terms of dose and format in 
which it can be effective.
Background
• Postoperative ileus: 
o Inability to recover gastrointestinal motility after 
abdominal surgery.
o Most common side effect in major abdominal 
surgeries.
o Multifactorial etiology. Related with opioids. 
• Pain and analgesia: 
o Abdominal surgeries are very painful procedure.
o The mainstay of postoperative analgesia remains 
opioids, which have many side effects.
o It tends to be a multimodal pain management.
Humans Animals
Primary results
Postoperative pain (rest) Effectiveness in the early period (1-4 
hours to 24 hours).
Gastrointestinal recovery 4.8% in lidocaine vs. 13.9% control of 
postoperative ileus.
Secondary results
Length of hospitalization There are studies that report a 
shortening and others do not.
Surgical complications 2’16% in lidocaine vs 1’44% control.
Postoperative nausea and vomiting Nausea of 20.1% lidocaine vs 28.4% 
control. Vomiting 2.6% lidocaine vs 5.8% 
control. In the hours leading up to 
surgery.
Opioid requirements Reduced throughout the recovery 
process.
Plasma levels of cytokines Decreased cytokines in lidocaine groups.
Side effects of lidocaine They are not reported or are mild 
symptoms.
Type of surgery benefited:
Laparoscopic surgery> Open abdominal surgery> other surgeries
Materials and methods
Search using the search engines Pubmed, Google Scholar and 
Mendeley.
Keywords: lidocaine, analgesia, postoperative, continuous 
infusion, abdominal surgery, horse, dog.
Articles with repeated concepts and data or that did not meet the 
search requirements were discarded.
Results
Postoperative reflux 65% lidocaine vs. 27% control at 30h ceased 
to have reflux. The amount also decreased 
by approximately 0.5%.
Time in defecation, borborygmus and 
feeding
1st defecation 6 hours before the 
treatments vs control. Food also before in 
treaties.
Postoperative complications There are no differences in gastrointestinal 
symptoms. Laminitis and incision discharge 
more prevalence in the control group.
Length of hospitalization A difference of about 5 days less in the 
treated than in the untreated.
Ultrasound examination There were differences in terms of 
inflammation and free fluid favoring the 
treated versus the untreated.
Dogs:
• 88.2% needed rescue analgesia in the control group versus 22.2% in the treated group.
• The pain in the control group increased after 1 hour, in that of lidocaine after 3 hours.
• When it becomes perioperative there is a drop in anesthetics in surgery. 45% in the case 
of halothane.
Horses:
Discusion
• In humans, the results are generally positive. There is an improvement in:
oReduction of analgesic requirements.
oAcceleration of intestinal recovery.
o Shortening of hospital stay.
o It does not appear to have serious side effects, although there are few studies that value it.
• In animals with respect to horses:
oOverall improvement of the parameters studied in the treated and untreated groups.
oBut there are many contradictions as to the results of each study, some have unreliable data for little sample.
• In animals with regard to dogs:
o The results were positive in some parameters but not in the same way as in equids.
oRegarding some other treatments, the results do not make it clear that lidocaine is a better option due to the effectiveness of NSAIDs, for 
example.
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Figure 1. Pharmacological properties of lidocaine (Beaussier 2018).
Table 1. Summary of humans results.
Table 2. Summary of horses results.
• Lidocaine: 
o Amide group anesthetic.
o Interesting for its effects as a treatment for intestinal ileus because it has anti-inflammatory effects such 
as suppression of histamine release form mast cells, decrease in albumin extravasation and microvascular 
permeability, inhibition of sequestration, migration and activation of polymorphonuclear cells, etc.
o The analgesic mechanisme effect is difficult to determine, we have two ways:
➢ Selectivness suppression of pain transmission in the spinal cord.
➢ Tonic neural discharge from active peripheral nerve fibers (Aδ and C, specially sensitive to lidocaine).
Mechanism of lidocaine
